Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study.

Pediatr Rheumatol Online J · 2021 · PMC8088679 · PMID 33933127

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep ≤ 0.08so close (0.05 < p ≤ 0.1)

mild disease; however this trend did not reach statistical significance ( p ≤ 0.08), likely due to limitations in sample size for moderate/severe IBD ( n = 8).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.